Medical comms - Press Releases

Date	Title	Company
23-Sep-2020	Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine	Salvia BioElectronics
23-Sep-2020	Aqilion announces identity of drug target and presents novel data from the drug discovery program Alnitak	Aqilion
23-Sep-2020	Interim results for the six months ended 30 June 2020 Strong performance from Consumer Healthcare brands; cash generation remains robust; full year results tracking in line with market expectations	ALLIANCE PHARMA PLC
23-Sep-2020	Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products	Nemaura Medical, Inc.
23-Sep-2020	Aqualung Therapeutics Corp. Awarded $300K from NIH to Develop A Novel Therapeutic For Pregn	Aqualung Therapeutics
23-Sep-2020	Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer	The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020	Lynparza recommended for approval in EU by CHMP as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer	AstraZeneca
23-Sep-2020	Lynparza recommended for approval in the EU by CHMP for BRCA-mutated metastatic castration-resistant prostate cancer	AstraZeneca
23-Sep-2020	Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial	AstraZeneca
23-Sep-2020	Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial	Novo Nordisk
23-Sep-2020	Preliminary Results for the year ended 30 June 2020	Allergy Therapeutics plc
23-Sep-2020	PureTech Plans U.S. Listing on Nasdaq Global Market	PureTech Health
23-Sep-2020	Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI)	Helsinn
23-Sep-2020	UCB Achieves Important Regulatory Milestone for Bimekizumab	UCB
23-Sep-2020	Thomas International launches new Talent Assessment Platform	Thomas International
21-Sep-2020	UCB launches Community Health Fund to support vulnerable young people post-COVID-19 crisis	UCB
21-Sep-2020	Vifor Pharma Group Announces Successful Sale of OM Pharma	Vifor Pharma
21-Sep-2020	Lawrence Whittard Obituary: Founder of Cherwell Laboratories	Cherwell Laboratories
21-Sep-2020	Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%	Sanofi
21-Sep-2020	ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP™ HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION	Abbott